Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
---|---|---|---|---|---|---|---|---|---|
UUS66989HAS7NOVARTIS CAP 20/50 | 6,50% | 0 | 64,02% | 2,75% | 2050-08-14 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | 5,78% | 10 K | 81,87% | 3,70% | 2042-09-21 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
XXPNDNOVARTIS CAPITAL 15/45 | 5,77% | 0 | 83,31% | 4,00% | 2045-11-20 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
UUS66989HAH1NOVARTIS CAPITAL 14/44 | 5,59% | 0 | 89,01% | 4,40% | 2044-05-06 | 1,85 B USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 | 5,58% | 767 K | 90,15% | 4,70% | 2054-09-18 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 | 5,08% | 3,9 M | 94,35% | 4,20% | 2034-09-18 | 1,1 B USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
UUS66989HAR9NOVARTIS CAP 20/30 | 4,98% | 0 | 88,06% | 2,20% | 2030-08-14 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
XXPNCNOVARTIS CAPITAL 15/25 | 4,76% | 0 | 98,75% | 3,00% | 2025-11-20 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 | 4,71% | 150 K | 96,46% | 4,00% | 2031-09-18 | 850 M USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 | 4,56% | 2,16 M | 97,14% | 3,80% | 2029-09-18 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
UUS66989HAN8NOVARTIS CAPITAL 17/27 | 4,46% | 0 | 97,25% | 3,10% | 2027-05-17 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 | 4,33% | 1,43 M | 95,77% | 2,00% | 2027-02-14 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Novartis Capital Corp. |
XXS176904160NOVARTIS FIN. 18/38 | 3,53% | 0 | 83,33% | 1,70% | 2038-08-14 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novartis Finance SA |
XXS176904119NOVARTIS FIN. 18/30 | 2,80% | 0 | 93,24% | 1,38% | 2030-08-14 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novartis Finance SA |
XXS223599621NOVARTIS FI. 20/28 | 2,70% | 0 | 91,17% | 0,00% | 2028-09-23 | 1,85 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novartis Finance SA |
XXS149282548NOVARTIS FIN. 16/28 | 2,53% | 0 | 93,75% | 0,63% | 2028-09-20 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novartis Finance SA |
NNOJANOVARTIS FIN. 17/27 | 2,38% | 0 | 96,92% | 1,13% | 2027-09-30 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novartis Finance SA |
XXS113472979NOVARTIS FIN. 14/26 | 2,34% | 0 | 98,83% | 1,63% | 2026-11-09 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novartis Finance SA |
1,31% | 0 | 109,92% | 1,85% | 2049-06-18 | 190 M CHF | 5.000,00 CHF | 5.000,00 CHF | Novartis AG | |
1,28% | 0 | 97,91% | 1,05% | 2035-05-11 | 325 M CHF | 5.000,00 CHF | 5.000,00 CHF | Novartis AG | |
1,26% | 0 | 107,57% | 1,85% | 2040-06-18 | 280 M CHF | 5.000,00 CHF | 5.000,00 CHF | Novartis AG | |
1,03% | 0 | 106,12% | 1,75% | 2034-06-16 | 645 M CHF | 5.000,00 CHF | 5.000,00 CHF | Novartis AG | |
0,94% | 0 | 104,24% | 1,65% | 2031-06-18 | 435 M CHF | 5.000,00 CHF | 5.000,00 CHF | Novartis AG | |
0,89% | 0 | 98,80% | 0,63% | 2029-11-13 | 550 M CHF | 5.000,00 CHF | 5.000,00 CHF | Novartis AG | |
0,65% | 0 | 102,16% | 1,60% | 2027-06-18 | 650 M CHF | 5.000,00 CHF | 5.000,00 CHF | Novartis AG | |
0,43% | 0 | 99,96% | 0,25% | 2025-05-13 | 500 M CHF | 5.000,00 CHF | 5.000,00 CHF | Novartis AG |